E-drug: Re: Malaria and antimalarials (cont)
-------------------------------------------------------------------------
Relevant to your last sentence "What we require are additional combinations
to the
existing one - where are the drug companies here?" See the following from
FDANews yesterday:
BAYER TO DEVELOP MALARIA TREATMENT
Bayer has signed an agreement with Medicines Malaria Venture, a World Heath
Organization initiative, to develop a new malaria medicine based on the
active ingredient artemisone, for which Bayer holds the patent rights. The
company said clinical trials for the product are slated to begin in 2003.
Nancy Blum, M.P.H., M.A.
Program Director,
Global Assistance Initiatives
U.S.Pharmacopeia
12601 Twinbrook Parkway
Rockville, MD 20852
(301) 816-8161
(301) 816-8374 FAX
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html